M. Mannel

发表

Dietary supplementation with the tribomechanically activated zeolite clinoptilolite in immunodeficiency: Effects on the immune system

S. Ivković, U. Deutsch, A. Silberbach, 2004, Advances in therapy.

Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.

W. Berger, U. Kuhn, M. Mannel, 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Drug Interactions with St John’s Wort

M. Mannel, 2001, Canadian family physician Medecin de famille canadien.

Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo.

M. Fava, A. Nierenberg, J. Rosenbaum, 2005, The international journal of neuropsychopharmacology.

Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).

W. Dimpfel, F. Schober, M. Mannel, 1998, Pharmacopsychiatry.

Effect of oral administration ofHypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation

J. Schulte‐Mönting, J. Simon, C. Schempp, 2003, Phytotherapy research : PTR.

Drug interactions with St John's wort : mechanisms and clinical implications.

M. Mannel, 2004, Drug safety.

Acute endocarditis in a patient with severe anorexia nervosa and autoaggressive behavior.

H. Deter, C. Weber, W. Köpp, 2007, Psychosomatics.

Treatment of Somatoform Disorders With St. John's Wort: A Randomized, Double-Blind and Placebo-Controlled Trial

H. Murck, T. Müller, V. Rahlfs, 2004, Psychosomatic medicine.

Drug Treatment in Juvenile Depression - Is St. John's Wort a Safe and Effective Alternative?

G. Seelinger, M. Mannel, 2007, Child and adolescent mental health.

Hypericum extract LI 160 and fluoxetine in mild to moderate depression

G. Edman, L. Bjerkenstedt, R. Alken, 2005, European Archives of Psychiatry and Clinical Neuroscience.

St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.

H. Murck, M. Ploch, U. Kuhn, 2010, Journal of psychiatric research.

5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis.

B. Müller-Oerlinghausen, M. Mannel, A. Czernik, 1997, Journal of affective disorders.

St. John's wort (Hypericum perforatum)--is it safe during breastfeeding?

C. Klier, G. Lenz, M. Schäfer, 2002, Pharmacopsychiatry.

Acute and chronic actions of a dry methanolic extract of Hypericum perforatum and a hyperforin-rich extract on dopaminergic and serotonergic neurones in rat nucleus accumbens.

H. Rommelspacher, M. Mannel, B. Siemanowitz, 2001, Pharmacopsychiatry.

Qualitative and quantitative olfactometric evaluation of different concentrations of ethanol peppermint oil solutions

T. Hummel, E. Pauli, D Krone, 2001, Phytotherapy research : PTR.

Acute effects of LI 160 (extract of Hypericum perforatum, St John's wort) and two of its constituents on neuroendocrine responses in the rat

P. Cowen, M. Franklin, M. Mannel, 2000, Journal of Psychopharmacology.